Skip to main content
Jeffrey Meyerhardt, MD, Oncology, Boston, MA

JeffreyAMeyerhardtMDMPH

Oncology Boston, MA

Gastrointestinal Cancer, Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Meyerhardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Meyerhardt's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Dana-Farber Cancer Inst
    Boston, MA 02215
    Phone+1 617-632-6855
    Fax+1 617-632-5370

Summary

  • Dr. Jeffrey Meyerhardt is an oncologist in Boston, MA and is affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital. He received his medical degree from Yale University School of Medicine and has been in practice 20 years. He specializes in gastrointestinal oncology.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2000 - 2002
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1997 - 2000
  • Yale School of Medicine
    Yale School of MedicineClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1999 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • RI State Medical License
    RI State Medical License 2020 - 2020
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Aspirin Use and Risk of Colorectal Cancer Among Older Adults  
    Long H Nguyen, Kimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, JAMA Oncology
  • Association of Diet Quality with Survival Among People with Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial  
    Kimmie Ng, Chloe Atreya, Howard S Hochster, James N Atkins, Richard M Goldberg, Charles D Blanke, Jeffrey A Meyerhardt, JAMA Network Open
  • Association of Coffee Intake with Survival in Patients with Advanced or Metastatic Colorectal Cancer  
    I-Wen Chang, Charles D Blanke, Alan P Venook, Richard M Goldberg, Jeffrey A Meyerhardt, Kimmie Ng, JAMA Oncology

Lectures

  • Lessons From IDEA: Duration in Stage II and III Colon Cancer 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Other

Authored Content

  • Vitamin D Status After Colorectal Cancer Diagnosis and Patient Survival According to Immune Response to TumourOctober 2018

Press Mentions

  • Chronic Stress Speeds Colorectal Cancer’s Spread Dramatically, Study Indicates
    Chronic Stress Speeds Colorectal Cancer’s Spread Dramatically, Study IndicatesOctober 12th, 2024
  • Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024
    Comprehensive cancer research from Dana-Farber to lead ESMO Congress 2024September 11th, 2024
  • Comprehensive Cancer Research from Dana-Farber to Lead ESMO Congress 2024
    Comprehensive Cancer Research from Dana-Farber to Lead ESMO Congress 2024September 9th, 2024
  • Join now to see all

Grant Support

  • Exercise And Metformin To Impact Hyperinsulinemia In Colorectal Cancer SurvivorsNational Cancer Institute2011
  • The Influence Of Diet And Lifestyle On Patients With Advanced Colorectal CancerNational Cancer Institute2010–2011
  • The Role Of Pi3-Kinase Signaling Pathway In Defining Sensitivity And ResistanceNational Cancer Institute2007–2011
  • Predictors Of Outcome In Colorectal CancerNational Cancer Institute2003–2007